久久综合日本久久综合,亚洲成AV人片在线观看天堂无码,国产在线视频不卡一区二区,久久久久看免费高清特色大片

武漢佰樂博生物技術(shù)有限公司
   
     
聯(lián)系熱線
  • 聯(lián)系人:方經(jīng)理
  • 電 話:027-65279366
  • 郵箱:products@biolabreagent.com
  • 地 址:武漢市東湖新技術(shù)開發(fā)區(qū)神墩四路666號(hào)C棟

佰樂博生物代理AntibodySystem,Anti-Mouse CD279/PDCD1/PD1 Antibody (29F.1A12)體內(nèi)中和抗體,活性抗體

發(fā)表時(shí)間:2024-05-29

鏈接:https://www.antibodysystem.com/product/14872.html

名稱:Anti-Mouse CD279/PDCD1/PD1 Antibody (29F.1A12)體內(nèi)中和抗體,活性抗體

別名:Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279

貨號(hào):FMH02220

宿主:Rat

適用物種:Mouse

存儲(chǔ)緩沖區(qū):0.01M PBS, pH 7.4, 0.09% Sodium azide.

形式:Liquid

純度:>95%

克?。?/span>Monoclonal

同型:IgG2a, kappa

應(yīng)用:FCM, IF, IHC, Neutralization, WB

內(nèi)毒素水平Please contact with the lab for this information.

UniProtQ02242

用途范圍:僅用于科研

儲(chǔ)存:Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

產(chǎn)品購買聯(lián)系方式:027-65279366 /18162686757

郵箱:biolab-reagents@atagenix.com

QQ:2663991332

 

參考文獻(xiàn):

CD279 mediates the homeostasis and survival of regulatory T cells by enhancing T cell and macrophage interactions. PMID: 32324337

Utility of CD279/PD-1 immunohistochemistry in the evaluation of benign and neoplastic T-cell-rich bone marrow infiltrates. PMID: 24926091

PD-1 Blockers. PMID: 26317459

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy. PMID: 30568661

Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma. PMID: 25011996

[Artesunate upregulates the expression of CD39, CD279 and granzyme B in CD4(+) and CD8(+) T lymphocytes of patients with lung cancer]. PMID: 35583064

PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL). PMID: 24359606

Different Induction of PD-L1 (CD274) and PD-1 (CD279) Expression in THP-1-Differentiated Types 1 and 2 Macrophages. PMID: 34675601

Effects of Tussilago farfara L. Polysaccharides on the Expression of PD-1 (CD279) and PD-L1 (CD274) in Peripheral Blood and Tumor Tissue Lymphocytes in Mice with Lewis Lung Carcinoma. PMID: 32749562

Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy. PMID: 37716115

[Next generation of anti-immune checkpoints antibodies]. PMID: 31903901

The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow. PMID: 29304116

CoViD-19 Immunopathology and Immunotherapy. PMID: 32308263

Expression patterns of the immunosuppressive proteins PD-1/CD279 and PD-L1/CD274 at different stages of cutaneous T-cell lymphoma/mycosis fungoides. PMID: 22094231

Peptide Blocking CTLA-4 and B7-1 Interaction. PMID: 33419027

PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma. PMID: 31620907

The association between polymorphisms in the PDCD1 gene and the risk of cancer: A PRISMA-compliant meta-analysis. PMID: 27749524

A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC? PMID: 33808740

PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases. PMID: 32937024

Epigenetic and Genetic Regulation of PDCD1 Gene in Cancer Immunology. PMID: 30178256

Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis. PMID: 35762356

Tumor Mutational Burden and Response Rate to PD-1 Inhibition. PMID: 29262275

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. PMID: 1396582

PD-L1/PD-1 checkpoint pathway regulates hippocampal neuronal excitability and learning and memory behavior. PMID: 37348508

Identification of PDCD1 as a potential biomarker in acute rejection after kidney transplantation via comprehensive bioinformatic analysis. PMID: 36776400

CBX4 promotes antitumor immunity by suppressing Pdcd1 expression in T cells. PMID: 37691307

PD1 signal transduction pathways in T cells. PMID: 28881701

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma. PMID: 35042524

Biomarkers for Predicting Efficacies of Anti-PD1 Antibodies. PMID: 31417907

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy. PMID: 34539412

Revisiting the PD-1 pathway. PMID: 32948597

PD1 Blockade in Cancer: Impact on Myeloid Cells. PMID: 32459997

Understanding the role of PD-L1/PD1 pathway blockade and autophagy in cancer therapy. PMID: 28367063

PD1 is transcriptionally regulated by LEF1 in mature T cells. PMID: 37523793

Emerging concepts in PD-1 checkpoint biology. PMID: 34006473

A Comparison of Murine PD-1 and PD-L1 Monoclonal Antibodies. PMID: 35925787

Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells. PMID: 35864188

Immunogenicity and antitumor efficacy of a novel human PD-1 B-cell vaccine (PD1-Vaxx) and combination immunotherapy with dual trastuzumab/pertuzumab-like HER-2 B-cell epitope vaccines (B-Vaxx) in a syngeneic mouse model. PMID: 33117602

聯(lián)系方式
手機(jī):18162686757
微信掃一掃
衢州市| 通州市| 绥江县| 汝阳县| 清镇市| 正蓝旗| 寻乌县| 京山县| 肥城市| 宜君县| 金坛市| 临海市| 邵阳市| 仁寿县| 松滋市| 名山县| 肇源县| 浦东新区| 沭阳县| 甘谷县| 岱山县| 新龙县| 大庆市| 讷河市| 灵山县| 贡觉县| 澜沧| 陵川县| 修武县| 枣阳市| 九江市| 阿拉善盟| 搜索| 大方县| 同德县| 贵州省| 上虞市| 贵德县| 台州市| 高淳县| 华亭县|